Skip to content

Prophylactic norepinephrine infusioin for hemodynamic effects during induction of general anesthesia using propofol in older patients

Prophylactic norepinephrine infusioin for hemodynamic effects during induction of general anesthesia using propofol in older patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200062864
Enrollment
Unknown
Registered
2022-08-22
Start date
2022-08-22
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

induction of general aneshesia

Interventions

intervention:Norepinephrine infusion
controll:saline infusion

Sponsors

Beijing Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged >= 65 years; 2. ASA class I-III; 3. Patients undergoing elective abdominal surgery under general anesthesia who need radial artery catheterization to directly measure arterial pressure and monitor cardiac output.

Exclusion criteria

Exclusion criteria: 1. Preoperative hypertension is not well controlled (average blood pressure measured in the ward within one week before operation is >= 160/90 mmhg); 2. Patients with primary aldosteronism, pheochromocytoma or other endocrine tumors; 3. A history of cardiac insufficiency, and the left ventricular ejection fraction (EF) < 50% in preoperative echocardiography; 4. Pacemaker implantation; 5. Patients with persistent atrial fibrillation; 6. A history of peripheral arterial disease; 7. Uremia requires hemodialysis; 8. Compound epidural anesthesia or other nerve block before general anesthesia induction; 9. Patients need to change from supine position to lateral or prone position after induction of general anesthesia; 10. Patients who are expected to have difficulty in endotracheal intubation; 11. Emergency operation; 12. Patients refuse to participate in the study.

Design outcomes

Primary

MeasureTime frame
cardiac index;pulse rate;

Secondary

MeasureTime frame
systemic vascular resistance index;

Countries

China

Contacts

Public ContactPeng Wenping

Beijing Hospital

wenping1031@163.com+86 13810074937

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026